This study is looking at whether questionnaires and follow-up can help people with bipolarity, Mood Swing, or Prodromal Symptoms. Participants take part in the program and complete follow-up questionnaires or assessments.

In Eindhoven

BipolarityBehavioralFrom 16 Years to 35 Years

Countries: Netherlands
Sponsor: Geestelijke Gezondheidszorg Eindhoven (GGzE)
Condition: Bipolarity

View study

CompletedNCT01841320

Seek, Test, Treat Strategies for Vietnamese Drug Users: A Controlled study

This study is completed in Vietnam. It focuses on Addiction.

In Hanoi

AddictionBehavioralOver 18 Years

Countries: Vietnam
Sponsor: Johns Hopkins University
Condition: Addiction

View study

WithdrawnNCT03816527

Selective Attention in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Mannheim

AddictionOtherFrom 18 Years to 65 Years

Countries: Germany
Sponsor: Central Institute of Mental Health, Mannheim
Condition: Addiction

View study

CompletedEUCTR 2010-019897-33

Selective D1 activation by addition of L-Dopa to antipsychotic treatment in people with schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Netherlands

SchizophreniaOther

Countries: Netherlands
Sponsor: erasmus mc
Condition: Schizophrenia

View study

CompletedNCT00361543

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Melbourne

SchizophreniaDrugFrom 45 Years to 70 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

View study

CompletedNCT01481883

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In Melbourne

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

View study

CompletedNCT02354001

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Melbourne

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

View study

CompletedNCT06185049

Selective Prevention Transdiagnostic Intervention for At-risk Adolescents With Booster Sessions. (PROCARE+ 2.0)

This summary needs review. Please check the official study record and contact the research team for details.

In Jaén

Addiction, Depression, ...BehavioralFrom 12 Years to 18 Years

Countries: Spain
Sponsor: University of Jaén
Condition: Addiction, Depression, ...

View study

TerminatedNCT01103180

Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago

SuicidalityDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: University of Chicago
Condition: Suicidality

View study

CompletedNCT00439413

Selegiline for Smoking Cessation - 1

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including College Park

AddictionBehavioralFrom 18 Years to 99 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.